A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI

Clinical trial NCT00751231 · COMPLETED

Trial details

NCT number: NCT00751231
Sponsor: Portola Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Percutaneous Coronary Intervention

Start date: 2008-12-01
Primary completion: 2010-04-01
Enrollment: 652

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.